$12.48 B
Share price
Change (1 day)
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Market capitalization of Bio-Techne (TECH)

Market cap: $12.48 Billion

As of June 2023 Bio-Techne has a market cap of $12.48 Billion. This makes Bio-Techne the world's 1266th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Bio-Techne from 2001 to 2023

End of year Market Cap

Year Market cap Change
2023$12.48 B-4.05%
2022$13.00 B-36%
2021$20.32 B65.81%
2020$12.26 B45.9%
2019$8.40 B53.88%
2018$5.46 B12.52%
2017$4.85 B26.5%
2016$3.83 B14.62%
2015$3.34 B-2.38%
2014$3.42 B-1.84%
2013$3.49 B38.75%
2012$2.51 B-0.31%
2011$2.52 B3.61%
2010$2.43 B-4.58%
2009$2.55 B5.61%
2008$2.41 B-6.6%
2007$2.58 B18.56%
2006$2.18 B0.17%
2005$2.18 B35.67%
2004$1.60 B3.5%
2003$1.55 B30.89%
2002$1.18 B-22.43%
2001$1.52 B

End of Day market cap according to different sources

On Jun 8th, 2023 the market cap of Bio-Techne was reported to be:

$12.48 Billion
by Yahoo Finance
$12.48 Billion
by CompaniesMarketCap
$12.48 Billion
by Nasdaq
$12.48 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$198.74 B 1,492.08%๐Ÿ‡บ๐Ÿ‡ธ USA
$70.86 B 467.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$115.64 B 826.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$173.70 B 1,291.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.36 B-16.99%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.10 B-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.44 B-16.31%๐Ÿ‡บ๐Ÿ‡ธ USA